← Every company
Moderna Inc Lobbying
What Moderna Inc discloses spending to lobby Congress, and who it pays to do it. Every lobbying firm files quarterly under the Lobbying Disclosure Act, naming its client, its fee and the issues it worked.
MRNA on carbonthat →Disclosed spend
$1.2M
across every filing on file
Filings
16
Years covered
1
Firms retained
4
What it lobbies about
Health IssuesTaxation/Internal Revenue CodeMedicare/Medicaid
16 filings
Newest year first, and within a year the largest fee first — a filing period is a word rather than a date, so it cannot order itself.
| Period | Lobbying for them | Disclosed |
|---|---|---|
| 20262nd Quarter (Apr 1 - June 30) | MODERNA, INC.Health Issues | $290K |
| 20261st Quarter (Jan 1 - Mar 31) | MODERNA, INC.Health Issues | $190K |
| 20262nd Quarter (Apr 1 - June 30) | HEALTH POLICY SOURCE, INC.Medicare/Medicaid | $100K |
| 20261st Quarter (Jan 1 - Mar 31) | BROWNSTEIN HYATT FARBER SCHRECK, LLPHealth Issues | $80K |
| 20262nd Quarter (Apr 1 - June 30) | BROWNSTEIN HYATT FARBER SCHRECK, LLPHealth Issues | $80K |
| 20261st Quarter (Jan 1 - Mar 31) | HEALTH POLICY SOURCE, INC.Medicare/Medicaid | $80K |
| 20261st Quarter (Jan 1 - Mar 31) | STANTON PARK GROUPHealth Issues | $50K |
| 20261st Quarter (Jan 1 - Mar 31) | AVENUE SOLUTIONSHealth Issues | $50K |
| 20262nd Quarter (Apr 1 - June 30) | STANTON PARK GROUPHealth Issues | $50K |
| 20262nd Quarter (Apr 1 - June 30) | AVENUE SOLUTIONSHealth Issues | $50K |
| 20261st Quarter (Jan 1 - Mar 31) | THE WASHINGTON TAX & PUBLIC POLICY GROUPTaxation/Internal Revenue Code | $30K |
| 20262nd Quarter (Apr 1 - June 30) | THE WASHINGTON TAX & PUBLIC POLICY GROUPTaxation/Internal Revenue Code | $30K |
| 20262nd Quarter (Apr 1 - June 30) | DGSR LLCHealth Issues | $20K |
| 20261st Quarter (Jan 1 - Mar 31) | HOLLAND & KNIGHT LLPTaxation/Internal Revenue Code | $20K |
| 20261st Quarter (Jan 1 - Mar 31) | DGSR LLCHealth Issues | $20K |
| 20262nd Quarter (Apr 1 - June 30) | HOLLAND & KNIGHT LLPTaxation/Internal Revenue Code | $20K |
A filing reports either the fee paid to a lobbying firm or what a company spent lobbying for itself, never both, so the total is a sum of the two. The client is named as filed, which is often a subsidiary. Lobbying is lawful, disclosed and extremely common — the figure is context, not an accusation.
More on MRNA
Company overviewEverything on MRNA in one place, with the price.SEC filingsWhat MRNA's 8-Ks say happened: results, departures, auditor changes.Insider tradingWhat MRNA's own officers and directors buy and sell.Planned salesSales MRNA insiders have filed notice of.Who owns itEvery manager reporting a position in MRNA.Funds holding itWhich funds and ETFs hold MRNA, and how big a bet.Who lobbies for itThe lobbyists on MRNA's account, and who they worked for.Federal contractsWhat federal agencies pay MRNA.PatentsWhat MRNA is filing at the patent office.